Lv2
150 积分 2023-09-07 加入
Sensitivity analyses for the principal ignorability assumption using multiple imputation
1天前
待确认
Invited Commentary: Why use methods that require proportional hazards?
1个月前
已完结
Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation
1个月前
已完结
Comparative analysis of two rates
1个月前
已完结
An adaptive seamless 2-in-1 design with biomarker-driven subgroup enrichment
2个月前
已完结
Extensions of the 2-in-1 adaptive design
2个月前
已完结
Return-to-baseline multiple imputation for missing values in clinical trials
7个月前
已关闭
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
7个月前
已完结
Multiple testing strategies for clinical trials with co-primary endpoints in all comers and a subgroup
10个月前
已关闭
皖公网安备34019202002308
